Practical Synthesis and Evaluation of the Biological Activities of 1α,25-dihydroxyvitamin D<sub>3</sub>Antagonists, 1α,25-dihydroxyvitamin D<sub>3</sub>-26,23-lactams. Designed on the Basis of the Helix 12-Folding Inhibition Hypothesis

Yusuke Nakano, Yuko Kato, Keisuke Imai, Eiji Ochiai, Junichi Namekawa, Seiichi Ishizuka, Kazuya Takenouchi, Aya Tanatani, Yuichi Hashimoto, Kazuo Nagasawa

Journal of Medicinal Chemistry · 2006 · 48 citations · 35 references

DOIFull text

Open access

Concepts

Abstract

A practical synthetic route to novel vitamin D antagonists of DLAM (1alpha,25-dihydroxyvitamin D(3)-26,23-lactam) was developed from vitamin D(2) via the 1,3-dipolar cycloaddition reaction as a key step. Six DLAM derivatives (24 compounds) with a variety of nitrogen substituents and stereochemistries at C23 and C25 were synthesized. Among these new derivatives, (23S,25S)-DLAM isomers bound effectively to VDRs and showed antagonistic activity in the HL-60 cell differentiation inhibition assay. The importance of the substituent on the nitrogen of DLAMs for antagonistic activity was also suggested by computational docking studies.

References

35